Document QkmKbp1VnMLE9Y9GpadL66q5E
Occupational and Environmental Medicine 1994;51:47-49
47
Exposure of workers to a mixture of toluene and xylenes. II Effects
Zhen Chen, Shi-Jie Liu, Shi-Xiong Cai, Yi-Min Yao, Hong Yin, Hirohiko Ukai, Yoko Uchida, Haruo Nakatsuka, Takao Watanabe, Masayuki Ikeda
Institute of Occupational Medicine, Chinese Academy of Preventive Medicine, Beijing, China Z Chen S-X Cai
Beijing Medical University School of Public Health, Beijing, China S-J Liu H Yin
Institute for Prevention and Treatment of Occupational Diseases, Bureau of Chemical Industry, Beijing City, Beijing, China Y M Kao
Department of Public Health, Kyoto University Faculty of Medicine, Kyoto 60601, Japan H Ukai Y Uchida M Ikeda
Kyoto Industrial Health Association, Kyoto 604, Japan H Ukai
Department of Environmental Sciences, Tohoku University School of Medicine, Sendai 980, Japan H Nakatsuka
Miyagi University of Education, Sendai 980, Japan T Watanabe
Requests for reprints to: Professor M Ikeda, Department of Public Health, Kyoto University Faculty of Medicine, Kyoto 606-01, Japan.
Accepted for publication 19 April 1993
Abstract The health effects of exposure to a mixture of toluene and xylene isomers was studied on the fourth or fifth days of a working week in factories in China. The study population comprised 233 subjects (122 men and 111 women), who were exposed to the time weighted geometric mean (maximum) concentrations of toluene (3 (203) ppm) and xylenes (4 (103) ppm). For comparison, 241 nonexposed controls (116 men and 125 women) were recruited from the same regions. The prevalence of some subjective symptoms significantly increased in the exposed population, and the symptom profiles were similar to those found after exposure to toluene or xylenes alone. Haematology and serum biochemistry did not show notable changes. It seems reasonable to conclude that the effects of the toxicities of toluene and xylenes in combination are additive.
(Occup Environ Med 1994;51:47-49)
Toluene (methylbenzene) and xylenes (three isomers of dimethylbenzene) are often present in combination in organic solvent preparations.'-3 Many reports from various countries have been published on exposure of workers,4"-l or of the general population.213 Whereas the toxicity of toluene has been extensively studied, reports on the health effects of xylenes alone are few; publications of the effects of toluene-xylene combinations on factory workers are rare, despite their wide use.
More than 200 workers exposed to toluene and xylenes in combination were examined in our study and compared with a similar number of non-exposed controls in a search for possible effects on the central nervous system, as well as haematological and serum biochemical effects. The lack of metabolic interaction between the solvents is reported
separately. 4
Materials and methods
SELECTION OF WORKERS AND DESIGN OF
HEALTH EXAMINATION
The study was carried out in China on the
fourth or fifth day of a working week.'4 The criteria of selection were that (1) the workers participated in the whole examination (personal diffusive sampling,'5-17 analysis of urine for monitoring of exposure, a questionnaire, haematology, and serum biochemistry for examination of effects on health), and (2) exposure was almost exclusively to toluene
and xylenes (>90%), but not toluene alone (no more than 90% toluene"8), xylenes alone (not more than 70% xylenes"9), or gasoline.
It was not possible beforehand to identify the workers who met the criteria. Accordingly, almost 1000 exposed workers were examined, of whom 233 subjects (122 men and 111 women) satisfied the two selection criteria. Some of them were exposed also to a few ppm ethylbenzene, but none was exposed to benzene.14 Non-exposed controls of 116 men and 125 women were recruited from the clerical sections of the same factory or factories in the same regions. Table 1 shows that there was no significant age difference between the sexes or between exposed and non-exposed populations. (p > 0-05 for both). Most exposures were low'4 with less than 10 ppm (geometric mean) for the sum of all exposures, although some workers were exposed to toluene and xylenes in excess of the current occupational exposure limit of
100 ppm of each.2>22 Health examination both for the exposed
and for the non-exposed persons consisted of (1) interview by a doctor or a public health nurse for medical history and completion of
questionnaires, (2) blood sampling for haematology and serum biochemistry for liver and kidney functions, (3) collection of urine for clinical urinary analysis by diagnostic kits, and (4) clinical examination (for details, see Ukai et al 18). Urine samples for metabolite analyses were collected at the end of the shift and on another separate occasion.2' The questionnaire has 12 questions on the symptoms during work and 57 questions (two
additional questions for women on menstruation) for the past three months (when not at work).24 25 The prevalence of the subjective
symptoms was calculated after Ukai et al 18 as: the number of affirmative answers by the group/(the number of the people in the group) x (number of questions) x 100 (%).
Table 1 Mean (y) age ofexposed and control workers
Workers
Men (SD, n)
Women (SD, n)
Exposed Controls
30 9 (8-0, 122) 33-8 (9-2, 116)
31-9 (7-2, 111) 31-8 (7-1, 125)
Men and women (SD, n) 31 4 (7-6, 233) 32-8 (8-3, 241)
STATISTICAL ANALYSIS
Significant differences in prevalences were tested for with the x 2 test, in means with a t test (one tailed) and in distribution with the Mann-Whitney U test.
48 Chen, Liu, Cai, Yao, Yin, Ukai, Uchida, Nakatsuka, Watanabe, Ikeda
Table 2 Prevalence ofsubjective symptoms
Subjective
symptoms Duringwork
Sex
Men Women Total
No of questions
12 12
Controls
71 (116):5-1 44 (125):2-9 115 (241):4-0
Exposed to toluene and xylenes
Total 1-20ppm
274 (122):18-7** 336 (111):25-2** 610 (233):21-8**
226 (91):20-7 285 (90):26-4 511 (181):23-5
In past three months Men 57 Women 59 Total
404 (116):5-9 540 (125):7-3 944 (241):6-6
884 (122):12-3** 1218 (111):18-6** 2102 (233):15-3**
769 (91):14-3 1056 (90):19 9 1825 (181):17-1
*p < 0-01
Values in
v controls. the table are
number
of
affirmative
answers
(number
of
subjects):percentage
prevalence.
>21 ppm
48 (31):12-9 51 (21):20-2 99 (52):15-9
115 (31):6-3 162 (21):13-1 277 (52):9 0
Table 3 Frequency distribution ofsubjective symptoms
Subjective symptoms
During work
Controls
Exposed
Sex I II III VI I II III IV
Men 85
Women 104 Total 189
22 9
17 4 39 13
0
0 0
23 74 19 6
18 52 26 15 41 126 45 21
Inpastthree months Men 20 91 5 Women 16 97 12 Total 36 188 17
0
0 0
13 83 18 8 6 55 36 14 18 138 54 22
p < 0 01 by x2 test in all cases. Values in the table are number of persons; categories I, fl, III, and IV were 0, 1-3, 4-6, and 7 or more symptoms during work, and 0, 1-10, 11-20 and 21 or more symptoms in past 3 months.
Table 4 Symptoms with significant difference (p < 0 01) in percentage prevalence (%) for men and women combined
Code No Symptom
Control (C)
Exposed (E)
EIC
During work: 1 Eye irritation 2 Dimmed vision 3 Nasal irritation 5 Sorethroat 6 Unusual taste 7 Face flashing
8 Dizziness 9 Floating sensation 11 Heavy feeling in the head
12 Headache
6-2 28-6
4-6
3-1 22-2
7-2
8-3 28-2
3-4
5 2 40-2
7-7
0 4 14-2 35-5
2-1 8-6 4-1
2-8 14-1
5-0
7 9 55-1
70
2-4 14-1
5-9
6-9 32-9
4-8
In the past 3 months:
4 Nausea 6 Difficulty in sleeping 7 Nightmare 13 Forgetfulness 14 Inability to concentrate 18 Fainting after sudden standing up 19 Palpitation 24 Poor appetite 26 Dry mouth 51 Roughskin
8-6
18-2
13-8 16-8
3-4 27-5 11-0 3-8 7.9 2-4
26-5
38-5 28-2 42-7
18-0 50-9 26-9 16-7 39.7
21-4
3-1
2-1
2-0 2-5 5-3 1-9 2-4 4-4 50 8-9
Code for each symptom is as in Yin et al.25
Results
PREVALENCE OF SUBJECTIVE SYMPTOMS
Table 2 shows that the prevalence of symp-
toms during work was significantly (p < 0 01) higher in the exposed than in the control group regardless of sex. This was also true for the prevalence of the symptoms in the past three months. As the response to two questions related to menstruation did not differ between exposed and control groups, the two sexes were combined after the exclusion of
these questions. When both exposed and non-exposed sub-
jects were classified by the number of symptoms per person, the frequency distribution was significantly (p < 0 01) different for both symptoms during work and in the past three
months (table 3). Table 4 gives prevalences for each symp-
tom with a significant increase (p < 0.01) in the exposed population. Most of the symptoms during work related depressive effects on the central nervous system (such as codes 9 and 11) or local irritation (codes 1, 3, and 5), whereas those in the past three month
period were less specific. The exposed to con-
trol ratio (E/I) ranged from 35-5 to 3A4 for
the work period and 8-9 to 19 for the past three months and was significantly higher (p < 0-05 by U test) in the work period than
in the past three months. For the detection of possible dose depen-
dency, exposed workers were classified into two subgroups by exposure intensities of 1 to 20 ppm and 21 ppm or more. Comparison of prevalences indicated no dose dependent increase either during work or in the past
three months (table 2).
Table S Comparison of haematology and serum biochemistry values
Men Women
Item (TJnit)
Exposed
Controls
Exposed
Controls
No of subjects
116
Haematology:
Haemoglobin (g/100 ml) 14-8 (1-1)
Leucocytes ( x 103/mm3) 6-70 (1-76)
Serum biochemistry:
Total protein (g/100 ml) 7-35 (0-51)
Total bilirubin (mg/I00 ml) 0 57 (0 29)*
y-GTP (U/1)
8-8 (1-60)*
ASAT(IU/1)
22-5-(1-38)
ALAT (IU/1)
23-9 (1-77)
ALP (IU/1)
260 (1-39)
LAP (IU/1)
48-9 (1-21)
Creatinine (mg/100 ml)
0-90 (0-12)*
122
14-8 (1-3) 6-46 (1-65)
7-34 (0 40) 0-67 (0 47) 10-2 (1-69) 21-5 (1-41) 22-1 (1-94) 254 (1-34) 47-1 (1-15) 0-87 (0-11)
125 111 12-7 (1-5) 12-5 (1-1) 6-31 (1-63) 6-34 (1-73) 7-54 (0-53) 7-48 (0 46) 0-51 (0.26)* 0 57 (0 29) 5 9 (1-70) 6-4 (1-75) 18-8 (1-38) 18-7 (1-38) 15-4 (1-84) 14-7 1-83) 202 (1-37) 206 (1-35) 42-1 (1-17) 41-2 (1-17) 0-71 (0-12)** 066 (0-09)
*p<0-05, **p <0-01. Values for haemoglobin,
leucocytes,
total
protein,
total
bilirubin
and
creatinine
are
arithmetic
mean (ASD), whereas those for y-GTP, ASAT, ALAT, ALP, and LAP are geometric mean
(GSD) with assumptions of normal and log normal distributions, respectively.
HAEMATOLOGY AND SERUM BIOCHEMISTRY
Table 5 shows the results of haematology and serum biochemistry tests. Because haemoglobin concentrations are known to be different in the two sexes the findings were treated separately for men and for women. Differences between exposed and control groups were not significant for most of the items, and none of the statistically significant differences were clinically relevant.
Discussion The health examination of 233 Chinese solvent workers occupationally exposed to a mixture of toluene and three xylene isomers at low concentrations and 241 controls showed that the prevalences of some subjec-
Exposure ofworkers to a mixture of toluene and xylenes. II Effects
49
tive symptoms were significantly increased in the study population. The symptom profiles were similar to those found after occupational exposure to toluene"' or xylenes,19 and focused on depression of the central nervous system and local irritation. In agreement with other observations,2627 haematology and serum biochemistry did not show noteworthy changes: this was also the case for workers exposed to toluenet8 or xylenes.19
The toxicity profiles are essentially the same for toluene, xylenes, and the mixture of the two, the central nervous system being the primary target. This suggests that it is justified when evaluating the toxicity of mixtures of toluene and xylenes at such low levels of occupational exposure, to add the effects.20 The current occupational exposure limits for toluene and three xylene isomers are set at 100 ppm2022 indicating that their potencies are essentially equal in their ability to depress the central nervous system.
We thank Professor C Jin of the Institute of Occupational Medicine, Chinese Academy of Preventive Medicine, Beijing, China, Professor T Suzuki (the former Director), and Professor K Yoshinaga of Tohoku Rosai Hospital, Sendai 980, Japan for their support to this study.
1 Inoue T, Takeuchi Y, Hisanaga N, Ono Y, Iwata M, Ogata M, et al. A nationwide survey on organic solvent components in various solvent products: Part I. Homogeneous products such as thinners, degreasers and reagents. Ind Health 1983;21:175-83.
2 Kumai M, Koizumi A, Saito K, Sakurai H, Inoue T, Takeuchi Y, et al. A nationwide survey on organic solvent components in various solvent products: Part II. Heterogeneous products such as paints, inks and adhesives. Ind Health 1983;21:185-97.
3 Seedorf L, Olsen E. Exposure to organic solvents-I. A survey on the use of solvents. Ann Occup Hyg 1990;34:371-8.
4 Ogata M, Takatsuka Y, Tomokuni K. Excretion of hippuric acid and m- or p-methylhippuric acid in the urine of persons exposed to vapours of toluene and m- or p-xylene in an exposure chamber and in workshops, with specific reference to repeated exposures. Br J Ind Med 1971;28:382-5.
5 Kurppa K, Husman K. Car painters' exposure to a mixture of organic solvents. Serum activities of liver enzymes. Scandj Work Environ Health 1982;8:137-40.
6 Iregren A. Effects on psychological test performance of workers exposed to a single solvent (toluene)-A comparison with effects of exposure to a mixture of organic solvents. Neurobehaviour Toxicology and Teratology 1982;4:695-701.
7 Lungberg I, Hakkansson M. Normal serum activities of liver enzyme in Swedish paint industry workers with heavy exposure to organic solvents. Br 7 Ind Med 1985;42:596-600.
8 Jonai H, Sato M. Exposure indices for painters exposed to toluene and xylene at low concentrations. Ind Health 1988;26:197-202.
9 Sakai T, Takeuchi Y, Ikeya Y, Arali T, Ushio K. Method for simultaneous determination of six metabolites of toluene, xylene and ethylbenzene, and its application to exposure -monitoring of workers -in a printing factory with gravure machines. Japanese Journal of Industrial Health 1989;31:9-16. (In Japanese with English abstract.)
10 Cho B-M. Urinary concentration of hippuric acid and methylhippuric acid after occupational exposure to toluene and xylene. Journal of Pusan Medical College 1989;29:109-19. (In Korean with English abstract.)
11 Chen JD, Wang JD, Jang JP, Chen YY. Exposure to mixtures of solvents among paint workers and biochemical alterations of liver function. Br Jf Ind Med 1991;48: 696-701.
12 Hajimiragha H, Ewers U, Brockhaus A, Boettiger A. Levels of benzene and other volatile aromatic compounds in the blood of non-smokers and smokers. Int
Arch Occup Environ Health 1989;61:513-8. 13 Chan C-C, Spengler JD, Ozkaynak H, Lefkopoulou M.
Commuter exposures to VOCs in Boston, Massachusetts. Jf Air Waste Manage Assoc 1991;41: 1594-600. 14 Huang M-H, Jin C, Liu Y-T, Li B-H, Qu Q-S, Uchida Y, et al. Mixed exposure of workers to toluene and xylenes. I Metabolism. Occup Environ Med 1994;51:42-6. 15 Hirayama T, Ikeda M. Applicability of carbon felt to the dosimetry of solvent vapor mixture. Am Ind Hyg Assoc J 1979;40: 1091-6. 16 Ikeda M, Kumai M, Aksoy M. Application of carbon felt dosimetry to field studies distant from analytical laboratory. Ind Health 1984;22:53-8. 17 Kasahara M, Ikeda M (1987) Spontaneous desorption of organic solvents from carbon cloth. Ind Health 1987;
25:73-81. 18 Ukai H, Watanabe T, Nakatsuka H, Satoh T, Liu S-J,
Qiao X, et al. Dose-dependent increase in subjective symptoms among toluene-exposed workers. Environ Res 1993;60:274-89. 19 Uchida Y, Nakatsuka H, Ukai H, Watanabe T, Liu Y-T, Huang M-Y, et al. Symptoms and signs of workers exposed predominantly to xylenes. Int Arch Occup Environ Health 1993;64:597-605. 20 American Conference of Governmental Industrial Hygienists. Threshold limit values and biological exposure indices for 1992-1993. Cincinnati: ACGIH, 1992. 21 Deutsche Forschungsgemeinschaft. Maximum concentrations at the workplace and biological tolerance values for working materials 1992. Weinheim: VCM, 1991. 22 Japan Association of Industrial Health. Recommended occupational exposure limits. Japanese Journal of Industrial Health 1992;34:363-84. (In Japanese.) 23 Liu SJ, Qu Q-S, Xu X-P, Lu Y-T, Yin S-N, Takeuchi Y, et al. Toluene vapor exposure and urinary excretion of
hippuric acid among Chinese workers. Am Jf Ind Med
1992;22:313-23. 24 Inoue T. A table of subjective symptom questionnaires for
solvent workers. In: Japan Industrial Safety and Health Association Health management of solvent workers. Tokyo: Japan Industrial Safety and Health Association, 1983: 66-67. 25 Yin S-N, Li G-L, Hu Y-T, Zhang X-M, Jin C, Inoue 0, et al. Symptoms and signs of workers exposed to benzene, toluene or the mixture. Ind Health 1987;25: 113-30. 26 Browning E. Toluene, and xylene. In: Toxicity and metabolism of industrial solvents. Amsterdam: Elsevier, 1965: 66-89. 27 Antti-Poika M, Kalliokowski P, Hanninen 0. Toluene. In: Snyder R, ed. Ethyl Browning's toxicity and metabolism of industrial solvents. Amsterdam: Elsevier, 1987: 36-63. 28 Riihimiki V, Pfdflli P, Savolainen K, Pekari K. Kinetics of m-xylene in man. General features of absorption, distribution, biotransformation and excretion in repetitive inhalation exposure. Scand J Work Environ Health 1979;5:217-31.